TABLE 2.
Characteristics of Interview Participants
Characteristic | N = 34 |
---|---|
Gender | |
Male | 16 (47.1%) |
Female | 16 (47.1%) |
Other | 2 (5.9%) |
Age [years] (Mean, SD) | 38.7 (8.0) |
<30 | 3 (8.8%) |
30–39 | 15 (44.1%) |
40–49 | 11 (32.4%) |
50+ | 5 (14.7%) |
Ethnicity | |
Not Hispanic | 28 (82.4%) |
Hispanic | 6 (17.6%) |
Race | |
African American | 1 (2.9%) |
American Indian/Alaska Native | 0 (0.0%) |
Asian or Pacific Islander | 0 (0.0%) |
White | 29 (85.3%) |
Multiracial | 3 (8.8%)* |
Other | 1 (2.9%) |
Heroin/Methamphetamine Use in Past 30 days | |
Heroin/opioids and methamphetamine/stimulants | 28 (82.4%) |
Heroin/opioids (no methamphetamine/stimulants) | 3 (8.8%) |
Methamphetamine/stimulants (no heroin/opioids) | 3 (8.8%) |
Injection Drug Use in Past 30 days | |
Yes | 30 (88.2%) |
No | 4 (11.8%) |
COVID-19 Vaccine Status | |
Received vaccine | 6 (17.6%) |
Have not received vaccine but plan to | 4 (11.8%) |
Have not received vaccine and do not plan to/unsure | 24 (70.6%) |
*All 3 were American Indian/Alaska Native and another race.